Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...

bradykinesia and postural instability. Nonmotor symptoms, such as depression, anxiety, psychosis, dementia, impulse-control disorders (ICDs), sleep disturbances and autonomic dysfunctions ...